Clinical Roundup Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy August 04, 2023Vol.49 No.31
Guest Editorial The new breast cancer screening guidelines are not enough to save Black womenA breast surgical oncologist and breast radiologist weigh in July 14, 2023Vol.49 No.28By Vivian Jolley Bea and Kemi Babagbemi
FreeObituary Susan Love, a transformative leader in breast cancer movement, dies at 75She intuitively understood the right thing to do—and then just did it July 07, 2023Vol.49 No.27By Frances M. Visco
FreeIn the Archives Remembering Susan Love, breast cancer oncologist and advocate July 07, 2023Vol.49 No.27
Drugs & Targets LoxiGen awarded three-year STTR grant to develop therapy for drug-resistant TNBC June 30, 2023Vol.49 No.26
Drugs & Targets FDA grants priority review to capivasertib + Faslodex for advanced HR-positive breast cancer June 16, 2023Vol.49 No.24
Clinical Roundup Race, ethnicity affect 21-gene recurrence score, OS in people with ER+ breast cancer June 09, 2023Vol.49 No.23
Clinical Roundup Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer June 09, 2023Vol.49 No.23
Clinical Roundup HERGain study shows potential for chemotherapy-free treatment of early HER2+ breast cancer June 09, 2023Vol.49 No.23
